Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
(Reuters) -Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as some U.S. states struggle with the treatment's costs, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results